Literature DB >> 18498789

Anatomic lung resection for nontuberculous mycobacterial disease.

John D Mitchell1, Amy Bishop, Amanda Cafaro, Michael J Weyant, Marvin Pomerantz.   

Abstract

BACKGROUND: Chronic lung infections involving nontuberculous mycobacteria are often inadequately treated owing to concomitant lung parenchymal damage, leading to persistence of the offending organisms. Little is known about the results of surgical therapy as part of a multimodality approach to these infections.
METHODS: A retrospective review was conducted of 236 consecutive patients who underwent anatomic lung resection for nontuberculous mycobacteria disease at our institution as part of a multimodality treatment program.
RESULTS: In all, 236 patients underwent 265 operations. The average age was 54 years (range, 23 to 77). Fifty-three patients had prior thoracic procedures. All patients had in-vitro sensitivity testing of cultured organisms, and had several months of guided antibiotic therapy. Special emphasis was placed on nutritional status. Eighty percent of patients had Mycobacterium avium complex disease. Anatomic lung resection was performed in all patients, with 126 lobectomies, 55 segmentectomies, 44 pneumonectomies, and 40 mixed procedures. Sixty-seven patients had either muscle or omental transposition. Mortality rate was 2.6%. The major morbidity rate was 11.7%. Average length of stay was 6.5 days. Presence on postoperative bronchopleural fistula was associated with positive sputum at operation and right pneumonectomy, particularly right completion pneumonectomy.
CONCLUSIONS: This series represents the largest cohort of patients in the literature to date who underwent operation for nontuberculous mycobacteria infection. Surgery for nontuberculous mycobacteria disease may be accomplished with minimal morbidity and mortality. A multidisciplinary approach including targeted antimicrobial therapy and complete anatomic resection is the key to success.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498789     DOI: 10.1016/j.athoracsur.2008.02.041

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  27 in total

Review 1.  Post-resection complications: abscesses, empyemas, bronchopleural fistulas.

Authors:  Matthew Egyud; Kei Suzuki
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 2.  Surgical management of non-cystic fibrosis bronchiectasis.

Authors:  Miyako Hiramatsu; Yuji Shiraishi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

3.  Acute empyema with intractable pneumothorax associated with ruptured lung abscess caused by Mycobacterium avium.

Authors:  Katsuyuki Asai; Norikazu Urabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

4.  Nontuberculous mycobacterial disease concomitant with a pulmonary artery occlusion caused by Takayasu's arteritis.

Authors:  Tomoshi Sugiyama; Koji Kawaguchi; Noriyasu Usami; Kohei Yokoi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-10-21

5.  Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience.

Authors:  Paul L Feingold; Humair S Quadri; Seth M Steinberg; Harry L Malech; John I Gallin; Christa S Zerbe; Kol A Zarember; Beatrice E Marciano; Steven M Holland; David S Schrump; Robert T Ripley
Journal:  J Clin Immunol       Date:  2016-08-06       Impact factor: 8.317

6.  Can physics principles help explain why non-tuberculous mycobacterial lung disease is more severe in the right middle lobe and lingula?

Authors:  Sangbong Choi; John C Richards; Edward D Chan
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

7.  Treatment of Non-Tuberculous Mycobacterial Lung Disease.

Authors:  Julie V Philley; Mary Ann DeGroote; Jennifer R Honda; Michael M Chan; Shannon Kasperbauer; Nicholas D Walter; Edward D Chan
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-11

8.  Wedge resection for localized infectious lesions: high margin/lesion ratio guaranteed operational safety.

Authors:  Yifeng Sun; Likun Hou; Huikang Xie; Hui Zheng; Gening Jiang; Wen Gao; Chang Chen
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

9.  Management of pulmonary nontuberculous mycobacterial disease.

Authors:  Kathleen L Horan; Shawn J Skerrett
Journal:  F1000 Med Rep       Date:  2009-12-15

Review 10.  Surgical treatment of nontuberculous mycobacterial lung disease.

Authors:  Yuji Shiraishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.